These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 15084912

  • 1. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
    Rosloniec EF, Whittington KB, He X, Stuart JM, Kang AH.
    Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
    [Abstract] [Full Text] [Related]

  • 2. HLA-DR1 (DRB1*0101) and DR4 (DRB1*0401) use the same anchor residues for binding an immunodominant peptide derived from human type II collagen.
    Rosloniec EF, Whittington KB, Zaller DM, Kang AH.
    J Immunol; 2002 Jan 01; 168(1):253-9. PubMed ID: 11751969
    [Abstract] [Full Text] [Related]

  • 3. Analog peptides of type II collagen can suppress arthritis in HLA-DR4 (DRB1*0401) transgenic mice.
    Sakurai Y, Brand DD, Tang B, Rosloniec EF, Stuart JM, Kang AH, Myers LK.
    Arthritis Res Ther; 2006 Jan 01; 8(5):R150. PubMed ID: 16982003
    [Abstract] [Full Text] [Related]

  • 4. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
    Rosloniec EF, Brand DD, Myers LK, Esaki Y, Whittington KB, Zaller DM, Woods A, Stuart JM, Kang AH.
    J Immunol; 1998 Mar 15; 160(6):2573-8. PubMed ID: 9510154
    [Abstract] [Full Text] [Related]

  • 5. An HLA-DR1 transgene confers susceptibility to collagen-induced arthritis elicited with human type II collagen.
    Rosloniec EF, Brand DD, Myers LK, Whittington KB, Gumanovskaya M, Zaller DM, Woods A, Altmann DM, Stuart JM, Kang AH.
    J Exp Med; 1997 Mar 17; 185(6):1113-22. PubMed ID: 9091584
    [Abstract] [Full Text] [Related]

  • 6. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
    He X, Rosloniec EF, Myers LK, McColgan WL, Gumanovskaya M, Kang AH, Stuart JM.
    Arthritis Rheum; 2004 Jun 17; 50(6):1996-2004. PubMed ID: 15188377
    [Abstract] [Full Text] [Related]

  • 7. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
    Myers LK, Sakurai Y, Tang B, He X, Rosloniec EF, Stuart JM, Kang AH.
    Arthritis Rheum; 2002 Dec 17; 46(12):3369-77. PubMed ID: 12483744
    [Abstract] [Full Text] [Related]

  • 8. Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses.
    Fridkis-Hareli M, Rosloniec EF, Fugger L, Strominger JL.
    Hum Immunol; 2000 Jul 17; 61(7):640-50. PubMed ID: 10880734
    [Abstract] [Full Text] [Related]

  • 9. An analog peptide that suppresses collagen-induced arthritis.
    Myers LK, Sakurai Y, Rosloniec EF, Stuart JM, Kang AH.
    Am J Med Sci; 2004 Apr 17; 327(4):212-6. PubMed ID: 15084917
    [Abstract] [Full Text] [Related]

  • 10. Breaking T cell tolerance against self type II collagen in HLA-DR4-transgenic mice and development of autoimmune arthritis.
    Batsalova T, Dzhambazov B, Merky P, Bäcklund A, Bäcklund J.
    Arthritis Rheum; 2010 Jul 17; 62(7):1911-20. PubMed ID: 20309862
    [Abstract] [Full Text] [Related]

  • 11. Immunopathogenesis of collagen arthritis.
    Brand DD, Kang AH, Rosloniec EF.
    Springer Semin Immunopathol; 2003 Aug 17; 25(1):3-18. PubMed ID: 12904888
    [Abstract] [Full Text] [Related]

  • 12. [The inhibitory effect of hyporesponsive peptide on human leukocyte antigen-DRbeta1 specific T cell activation].
    Zhou Q, Cheng YJ, Li ZG, Zhou WH, Lu HS.
    Zhonghua Yi Xue Za Zhi; 2003 Sep 10; 83(17):1505-9. PubMed ID: 14521731
    [Abstract] [Full Text] [Related]

  • 13. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.
    von Delwig A, Altmann DM, Isaacs JD, Harding CV, Holmdahl R, McKie N, Robinson JH.
    Arthritis Rheum; 2006 Feb 10; 54(2):482-91. PubMed ID: 16447222
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Definition of MHC and T cell receptor contacts in the HLA-DR4restricted immunodominant epitope in type II collagen and characterization of collagen-induced arthritis in HLA-DR4 and human CD4 transgenic mice.
    Andersson EC, Hansen BE, Jacobsen H, Madsen LS, Andersen CB, Engberg J, Rothbard JB, McDevitt GS, Malmström V, Holmdahl R, Svejgaard A, Fugger L.
    Proc Natl Acad Sci U S A; 1998 Jun 23; 95(13):7574-9. PubMed ID: 9636191
    [Abstract] [Full Text] [Related]

  • 16. Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints.
    Latham KA, Whittington KB, Zhou R, Qian Z, Rosloniec EF.
    J Immunol; 2005 Apr 01; 174(7):3978-85. PubMed ID: 15778354
    [Abstract] [Full Text] [Related]

  • 17. CD8+ T Cells Expressing an HLA-DR1 Chimeric Antigen Receptor Target Autoimmune CD4+ T Cells in an Antigen-Specific Manner and Inhibit the Development of Autoimmune Arthritis.
    Whittington KB, Prislovsky A, Beaty J, Albritton L, Radic M, Rosloniec EF.
    J Immunol; 2022 Jan 01; 208(1):16-26. PubMed ID: 34819392
    [Abstract] [Full Text] [Related]

  • 18. HLA-DM negatively regulates HLA-DR4-restricted collagen pathogenic peptide presentation and T cell recognition.
    Amria S, Hajiaghamohseni LM, Harbeson C, Zhao D, Goldstein O, Blum JS, Haque A.
    Eur J Immunol; 2008 Jul 01; 38(7):1961-70. PubMed ID: 18506881
    [Abstract] [Full Text] [Related]

  • 19. Crystallographic structure of a rheumatoid arthritis MHC susceptibility allele, HLA-DR1 (DRB1*0101), complexed with the immunodominant determinant of human type II collagen.
    Rosloniec EF, Ivey RA, Whittington KB, Kang AH, Park HW.
    J Immunol; 2006 Sep 15; 177(6):3884-92. PubMed ID: 16951351
    [Abstract] [Full Text] [Related]

  • 20. HLA-DR1 and DRw6 association in DR4-negative rheumatoid arthritis patients.
    Lang B, Melchers I, Urlacher A, Tanzi-Fetta RF, Kohlbrenner S, Tongio MM, Peter HH.
    Rheumatol Int; 1990 Sep 15; 10(4):171-5. PubMed ID: 2259843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.